Same experience with Fable. Utterly useless for anything bio related.
Author of the post here wrote Salmon, which is a widely used bioinformatic tool in molecular biology. And the irony is that Anthropic has probably packaged Salmon as a tool in their Claude for Science suite with now remuneration or recognition for the original author.
There has been a lot of recent bs going on in biomed ML with companies publishing without releasing source code, restrictive licenses, etc; which have always given off a whiff of bad citizenship - Ark Institute and Deep Mind I am looking at you - but I feel like this is taking it to a new level.
Leveraging open source bioinformatics code and published methods to take in profit selling into the biotech vertical while restricting access to Fable feels downright cancerous. I think the EA crowd at Anthropic probably has good intentions, but has galaxy brained themselves into becoming bad actors that make Sam Altman and OpenAI look like a paragon of trustworthiness in comparison.
Author of the post here wrote Salmon, which is a widely used bioinformatic tool in molecular biology. And the irony is that Anthropic has probably packaged Salmon as a tool in their Claude for Science suite with now remuneration or recognition for the original author.
There has been a lot of recent bs going on in biomed ML with companies publishing without releasing source code, restrictive licenses, etc; which have always given off a whiff of bad citizenship - Ark Institute and Deep Mind I am looking at you - but I feel like this is taking it to a new level.
Leveraging open source bioinformatics code and published methods to take in profit selling into the biotech vertical while restricting access to Fable feels downright cancerous. I think the EA crowd at Anthropic probably has good intentions, but has galaxy brained themselves into becoming bad actors that make Sam Altman and OpenAI look like a paragon of trustworthiness in comparison.